Y Intercept Hong Kong Ltd Purchases Shares of 6,518 Trupanion, Inc. (NASDAQ:TRUP)

Key Points

• Y Intercept Hong Kong Ltd has acquired a new stake in Trupanion, Inc. (NASDAQ:TRUP) by purchasing 6,518 shares, valued at approximately $243,000.
• Trupanion reported a quarterly revenue of $341.98 million, exceeding analyst estimates and showing an 11.7% increase year-over-year.
• Wall Street analysts have a consensus rating of "Moderate Buy" for Trupanion, with an average target price of $53.80, following a series of price target adjustments from various firms.

Y Intercept Hong Kong Ltd purchased a new position in shares of Trupanion, Inc. (NASDAQ:TRUP - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 6,518 shares of the financial services provider's stock, valued at approximately $243,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the company. Balyasny Asset Management L.P. lifted its position in Trupanion by 368.2% during the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after buying an additional 661,559 shares in the last quarter. BNP Paribas Financial Markets lifted its position in shares of Trupanion by 170.7% during the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock worth $16,248,000 after purchasing an additional 212,545 shares in the last quarter. Freestone Grove Partners LP acquired a new position in shares of Trupanion during the fourth quarter worth $7,776,000. First Trust Advisors LP acquired a new position in shares of Trupanion during the fourth quarter worth $7,083,000. Finally, Dimensional Fund Advisors LP lifted its position in shares of Trupanion by 112.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider's stock worth $13,204,000 after purchasing an additional 144,828 shares in the last quarter.

Wall Street Analyst Weigh In

TRUP has been the subject of a number of research analyst reports. Lake Street Capital dropped their price target on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research note on Friday, May 2nd. Piper Sandler lifted their price target on shares of Trupanion from $52.00 to $62.00 and gave the stock an "overweight" rating in a research note on Thursday, July 3rd. Two analysts have rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $53.80.

Trupanion Stock Down 2.5%

Shares of NASDAQ TRUP traded down $1.20 during mid-day trading on Friday, reaching $46.21. 551,932 shares of the company's stock were exchanged, compared to its average volume of 448,143. The firm has a market capitalization of $1.98 billion, a price-to-earnings ratio of -462.05 and a beta of 1.78. The company has a current ratio of 1.70, a quick ratio of 1.70 and a debt-to-equity ratio of 0.38. The business has a fifty day simple moving average of $50.99 and a 200 day simple moving average of $43.98. Trupanion, Inc. has a twelve month low of $29.70 and a twelve month high of $57.90.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. Trupanion had a negative return on equity of 1.33% and a negative net margin of 0.32%. The firm had revenue of $341.98 million for the quarter, compared to analyst estimates of $337.81 million. During the same quarter in the previous year, the firm earned ($0.16) EPS. The business's quarterly revenue was up 11.7% on a year-over-year basis. As a group, equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current fiscal year.

Insider Activity

In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the business's stock in a transaction dated Tuesday, May 20th. The stock was sold at an average price of $45.86, for a total transaction of $183,440.00. Following the completion of the transaction, the chief executive officer owned 118,784 shares of the company's stock, valued at approximately $5,447,434.24. The trade was a 3.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $48.31, for a total value of $122,417.54. Following the completion of the transaction, the chief financial officer owned 3,545 shares of the company's stock, valued at $171,258.95. This represents a 41.68% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 11,562 shares of company stock worth $544,870. 5.42% of the stock is currently owned by company insiders.

Trupanion Company Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.